Projects funded by the NCN
Gankyrin protein as a new potential therapeutic target in multiple myeloma
2019/35/B/NZ5/02824
Keywords:
multiple myeloma proteins gankyrin biomarkers drug resistance terapeutic target CRISPR RNAi transcriptome
Descriptors:
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Hematologii i Transfuzjologii
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 18 - announced on 2019-09-16
Amount awarded: 3 221 640 PLN
Project start date (Y-m-d): 2020-10-05
Project end date (Y-m-d): 2024-10-04
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.